Founding Director
Prof. Amir Amedi
Co-founder and Chief Scientific Officer, Remepy; Professor, School of Medicine and School of Psychology, Reichman University; Founding Director, Baruch Ivcher Institute for Brain, Cognition & Technology and Ruth and Meir Rosental Brain Imaging Center
Amir Amedi co-founded Remepy, pioneer of Hybrid Drugs, where his research spans disease areas in which integrating multisensory top-down and bottom-up digital interventions can improve clinical outcomes. At Reichman University his institute studies the human brain in health and disease and its interface with technology.
He was previously Professor of Medical Neurobiology and Cognitive Sciences at the Hebrew University, where he completed his PhD in computational neuroscience (2005). His training spans computational neuroscience, brain imaging, neurology (as a visiting fellow at NIH/NINDS and Instructor in Neurology at Harvard Medical School) and music.
He has published over 150 papers and book chapters, including more than 50 in top-quartile journals such as Nature Neuroscience, Nature Communications and npj Digital Medicine, and holds over 20 patents (granted or under review). Awards include the Wolf Foundation's Krill Prize (2011), the McDonnell Foundation Scholar Award (2011), Human Frontier Science Program fellowships (2004, 2009), and European Research Council Starting (2013), Consolidator (2017) and Proof of Concept (2023) grants.
Follow Prof. Amedi
